Management of Full-Term Newborns with Elevated CRP

Evaluation and Assessment

The American Academy of Pediatrics recommends a comprehensive clinical evaluation, rather than a single CRP value, to determine the need for antibiotic therapy in newborns, considering factors such as clinical status, maternal risk factors, and perinatal conditions 1, 2
A healthy-appearing newborn with no maternal risk factors and a CRP level of 11.4 mg/L on the first day of life has a low risk of infection, with a sensitivity of 35-39% for proven sepsis and 39-64% for proven or probable sepsis 3, 1
Maternal risk factors, such as intrapartum fever ≥38°C, chorioamnionitis, or inadequate intrapartum antibiotic prophylaxis, increase the risk of neonatal infection 4, 1, 5

The Centers for Disease Control and Prevention recommend a full diagnostic evaluation, including blood culture, complete blood count with differential, and platelet count, for newborns with suspected sepsis or maternal risk factors 1, 2
Antibiotic therapy should be initiated promptly in newborns with suspected sepsis or maternal risk factors, with a combination of ampicillin and gentamicin as first-line therapy 1, 2

The American Academy of Pediatrics recommends close observation for 48 hours without antibiotics for healthy-appearing newborns without maternal risk factors, with monitoring of vital signs and clinical status every 4-6 hours 1, 2, 4
Serial CRP measurements can guide the duration of antibiotic therapy, with a negative predictive value of 99% for infection when CRP levels decrease to <10 mg/L 1, 2
Antibiotic therapy can be safely discontinued when CRP levels return to <10 mg/L, usually within 3-4 days, without increasing the risk of relapse 1, 2